Respiratory Agents Flashcards
SNS lung innervation
from thoracic ganglia, innervates smooth muscles of bronchi and pulmonary blood vessels
PSNS lung innervation
via vagus nerve, bronchoconstriction via mostly M3 and a little bit of M1
B2 adrenoreceptors cause (intracellular response)
increased intracellular cAMP which changes membrane potential of cells and decreases calcium release intracellularly, greater sensitivity to EPI v NE
Non adrenergic non cholinergic nerves (NANC)
excitatory: related to substance p and neurokinin
inhibitory: NO, peptide release
How do M3 mediate bronchoconstriction
via activation of IP3 (inositol triphosphate) which increases intracellular Ca2+ concentrations. also mediates mucous secretion.
asthma histologic mediators include
eosinophils, mast cells, neutrophils, macrophages, basophils, t lymphocytes, cytokines, interleukins, arachidonic acid metabolites, leukotrienes, prostaglandins, histamine, adenosine, platelet activating factor
emphysema/bronchitis pathological result
enlargement of air spaces, fibrosis, increased mucous production
treatment of airway outflow disorders (5 steps)
- short acting bronchodilators
- inhaled corticosteroids
- long acting bronchodilators
- PD3 inhibitors, methylxanthines, leukotriene inhibitor
- oral corticosteroid
bronchodilator med classes
beta agonists
anticholinergics
methylxanthines
short acting beta agonists (SALT)
terbutaline, albuterol, levalbuterol, salbutamol
long acting beta agonists
salmeterol, formoterol
B2 agonist bronchodilator MOA (general)
(3,5 cAMP production)
activate adenyl cyclase which increases production of cAMP (adenosine monophosphate) which causes bronchodilation. reduced intracellular calcium release and alters membrane conductance
B2 agonist bronchodilator effects (general desirable effects)
dilates bronchi, smooth muscle relaxation, inhibits mediator release from mast cells, increase mucus clearance by action in cells
B2 agonist SE’s (general)
minimized by inhalation delivery tremor increased HR vasodilation metabolic changes including hyperglycemia, hypokalemia, hypomagnesemia
Albuterol class, dose, route of administration (2), duration of action, SE’s
beta 2 agonist
administered via metered dose at 100mcg/puff
2 puffs q4-6h
neb 2.5-5mg in 5ml of saline
can give 4 puffs to blunt AW response to tracheal intubation for asthmatics
duration 4 hours with relief evident up to 8h (additive effect with volatile anesthetics)
SE: tachycardia, hypokalemia,
isomers of albuterol
R albuterol levalbuterol- more affinity for B2
S albuterol more affinity for B1
Metaproterenol-Alupent class, route of administration, dose max
beta 2 agonist used for tx of asthma, administered via metered dose, dont exceed 16 puffs per day
Pirbuterol-Maxair class, dose, dose max
beta 2 agonist, administered via metered dose (400mcg), do not exceed 12 puffs/day